Devito v. Secretary of Health and Human Services
Opinion
In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 23-164V ************************* * RALPH DEVITO, * Chief Special Master Corcoran * Petitioner, * Filed: October 6, 2025 * v. * * SECRETARY OF HEALTH * AND HUMAN SERVICES, * * Respondent. * * ************************* Nancy R. Meyers, Turning Point Litigation, Greensboro, NC, for Petitioner.
Jay T. Williamson, U.S. Department of Justice, Washington, DC, for Respondent.
DECISION AWARDING DAMAGES 1 On September 15, 2025, Ralph Devito filed a petition seeking compensation under the National Vaccine Injury Compensation Program (the “Vaccine Program”). 2 Petitioner alleges that his receipt of the influenza (“flu”) vaccine he received on October 13, 2021, caused him to develop Guillain-Barré syndrome (“GBS”) within the time period set forth in the Table, or in the alternative, that his neuropathy was caused-in-fact by the flu vaccine. Moreover, Petitioner alleges that he experienced residual effects of this injury for more than six months.
Respondent denies that Petitioner sustained a Table injury, denies that the flu vaccine caused Petitioner’s neuropathic injury, or any other injury or condition. Respondent also denies that Petitioner’s current condition is a sequela of a vaccine-related injury. Nonetheless, both Under Vaccine Rule 18(b), each party has fourteen (14) days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the whole Decision will be available to the public in its present form. Id. The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”).
Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). parties, while maintaining their above-stated positions, agreed in a stipulation (filed on October 6, 2025) that the issues before them could be settled, and that a decision should be entered awarding Petitioner compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation (as attached hereto) is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth therein.
The stipulation awards: • A lump sum of $75,000.00 to be paid through an ACH deposit to Petitioner’s counsel’s IOLTA account for prompt disbursement to Petitioner.
Stipulation ¶ 8. This amount represents compensation for all damages that would be available under Section 15(a) of the Act.
I approve a Vaccine Program award in the requested amount set forth above to be made to Petitioner. In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of the Court is directed to enter judgment herewith. 3
IT IS SO ORDERED.
/s/ Brian H. Corcoran Brian H. Corcoran Chief Special Master
Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by each filing (either jointly or separately) a notice renouncing their right to seek review.
Case-law data current through December 31, 2025. Source: CourtListener bulk data.